Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Tracy D Bates, APRN
Nurse Practitioner · OSAGE CITY, KS · NPI 1174063580
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 528 | 43 |
| Atorvastatin Calcium | Atorvastatin Calcium | 494 | 68 |
| Amlodipine Besylate | Amlodipine Besylate | 431 | 35 |
| Pantoprazole Sodium | Pantoprazole Sodium | 421 | 43 |
| Levothyroxine Sodium | Levothyroxine Sodium | 295 | 34 |
| Furosemide | Furosemide | 285 | 26 |
| Eliquis | Apixaban | 259 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 251 | 18 |
| Montelukast Sodium | Montelukast Sodium | 237 | 26 |
| Lisinopril | Lisinopril | 236 | 24 |
| Losartan Potassium | Losartan Potassium | 232 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 221 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 198 | 15 |
| Carvedilol | Carvedilol | 197 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 196 | 19 |
| Trazodone Hcl | Trazodone Hcl | 194 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 176 | 11 |
| Metformin Hcl | Metformin Hcl | 175 | 25 |
| Simvastatin | Simvastatin | 173 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 167 | 11 |
| Metoprolol Succinate | Metoprolol Succinate | 166 | 17 |
| Potassium Chloride | Potassium Chloride | 164 | 18 |
| Ezetimibe | Ezetimibe | 161 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 12 |
| Bupropion Xl | Bupropion Hcl | 149 | 11 |
| Pregabalin | Pregabalin | 143 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 139 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 138 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 135 | 12 |
| Famotidine | Famotidine | 133 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 122 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 118 | suppressed |
| Meloxicam | Meloxicam | 108 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 106 | suppressed |
| Glipizide Er | Glipizide | 103 | 12 |
| Omeprazole | Omeprazole | 94 | 17 |
| Glipizide | Glipizide | 93 | 13 |
| Sertraline Hcl | Sertraline Hcl | 89 | suppressed |
| Spironolactone | Spironolactone | 85 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 83 | 13 |
| Sevelamer Carbonate | Sevelamer Carbonate | 82 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 80 | suppressed |
| Methotrexate | Methotrexate Sodium | 80 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 79 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 76 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 75 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 74 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 72 | suppressed |
| Torsemide | Torsemide | 72 | suppressed |
| Aripiprazole | Aripiprazole | 69 | suppressed |
| Risperidone | Risperidone | 69 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 67 | 13 |
| Irbesartan | Irbesartan | 65 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 61 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 60 | suppressed |
| Ramelteon | Ramelteon | 60 | suppressed |
| Celecoxib | Celecoxib | 58 | suppressed |
| Dofetilide | Dofetilide | 58 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 58 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 56 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 55 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 53 | suppressed |
| Calcitriol | Calcitriol | 53 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 52 | suppressed |
| Finasteride | Finasteride | 52 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 51 | suppressed |
| Gemfibrozil | Gemfibrozil | 50 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | suppressed |
| Ranolazine Er | Ranolazine | 48 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 47 | suppressed |
| Kerendia | Finerenone | 47 | suppressed |
| Baclofen | Baclofen | 46 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 46 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 46 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 45 | suppressed |
| Colchicine | Colchicine | 44 | suppressed |
| Allopurinol | Allopurinol | 43 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 43 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 42 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | suppressed |
| Jardiance | Empagliflozin | 41 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 38 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 37 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 35 | 27 |
| Megestrol Acetate | Megestrol Acetate | 35 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 32 | suppressed |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Prednisone | Prednisone | 32 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 31 | suppressed |
| Entresto | Sacubitril/Valsartan | 30 | suppressed |
| Clonazepam | Clonazepam | 28 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Metolazone | Metolazone | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 24 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 24 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Mirtazapine | Mirtazapine | 22 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 21 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Calcium Acetate | Calcium Acetate | 19 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 19 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 19 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Etodolac | Etodolac | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error